AAAAAA

   
Results: 1-8 |
Results: 8
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine
Authors: McFarland, EJ Borkowsky, W Fenton, T Wara, D McNamara, J Samson, P Kang, MH Mofenson, L Cunningham, C Duliege, AM Sinangil, F Spector, SA Jimenez, E Bryson, Y Burchett, S Frenkel, LM Yogev, R Gigliotti, F Luzuriaga, K Livingston, RA
Citation: Ej. Mcfarland et al., Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine, J INFEC DIS, 184(10), 2001, pp. 1331-1335
Shipment impairs lymphocyte proliferative responses to microbial antigens
Authors: Betensky, RA Connick, E Devers, J Landay, AL Nokta, M Plaeger, S Rosenblatt, H Schmitz, JL Valentine, F Wara, D Weinberg, A Lederman, HM
Citation: Ra. Betensky et al., Shipment impairs lymphocyte proliferative responses to microbial antigens, CL DIAG LAB, 7(5), 2000, pp. 759-763
Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns
Authors: Kliks, S Contag, CH Corliss, H Learn, G Rodrigo, A Wara, D Mullins, JI Levy, JA
Citation: S. Kliks et al., Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns, AIDS RES H, 16(13), 2000, pp. 1223-1233
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: Phase 1/2 study
Authors: Shearer, WT Israel, RJ Starr, S Fletcher, CV Wara, D Rathore, M Church, J DeVille, J Fenton, T Graham, B Samson, P Staprans, S McNamara, J Moye, J Maddon, PJ Olson, WC
Citation: Wt. Shearer et al., Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: Phase 1/2 study, J INFEC DIS, 182(6), 2000, pp. 1774-1779
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines
Authors: Borkowsky, W Wara, D Fenton, T McNamara, J Kang, MH Mofenson, L McFarland, E Cunningham, C Duliege, AM Francis, D Bryson, Y Burchett, S Spector, SA Frenkel, LM Starr, S Van Dyke, R Jimenez, E
Citation: W. Borkowsky et al., Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines, J INFEC DIS, 181(3), 2000, pp. 890-896
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273)
Authors: Stiehm, ER Fletcher, CV Mofenson, LM Palumbo, PE Kang, MH Fenton, T Sapan, CV Meyer, WA Shearer, WT Hawkins, E Fowler, MG Bouquin, P Purdue, L Sloand, EM Nemo, GJ Wara, D Bryson, YJ Starr, SE Petru, A Burchett, S
Citation: Er. Stiehm et al., Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273), J INFEC DIS, 181(2), 2000, pp. 548-554
Sleep disturbances in children with human immunodeficiency virus infection
Authors: Franck, LS Johnson, LM Lee, K Hepner, C Lambert, L Passeri, M Manio, E Dorenbaum, A Wara, D
Citation: Ls. Franck et al., Sleep disturbances in children with human immunodeficiency virus infection, PEDIATRICS, 104(5), 1999, pp. J1-J5
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children
Authors: Lambert, JS McNamara, J Katz, SL Fenton, T Kang, MH VanCott, TC Livingston, R Hawkins, E Moye, J Borkowsky, W Johnson, D Yogev, S Duliege, AM Francis, L Gershon, A Wara, D Martin, N Levin, F McSherry, F Smith, G
Citation: Js. Lambert et al., Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children, J ACQ IMM D, 19(5), 1998, pp. 451-461
Risultati: 1-8 |